Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kleanthis Xanthopoulos

Premium

Privately held transdermal drug delivery firm Zosano Pharma said it has appointed Kleanthis Xanthopoulos to its board of directors.

Xanthopolis is currently president and CEO of microRNA drug developer Regulus Therapeutics. Prior to that, he was a co-founder and president/CEO of Anadys Pharmaceuticals.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.